More than 100 public health, science, research and medical organizations are urging the White House to reverse a new policy that would divert COVID-19 patient data collection from the U.S. Centers for Disease Control and Prevention.
More than 100 public health, science, research and medical organizations are urging the White House to reverse a new policy that would divert COVID-19 patient data collection from the U.S. Centers for Disease Control and Prevention.
The House Labor, Health and Human Services bill passed by the full Appropriations Committee on July 13, and the State and Foreign Operations Appropriations bills passed by the full committee on July 9, provide critical resources to confront and curtail the COVID-19 pandemic’s impacts at home and abroad.
The administration’s decision to withdraw the United States from the World Health Organization comes at a juncture of the COVID-19 pandemic when more than 12.1 million people have been diagnosed with COVID-19 and more than 550,000 people have died worldwide.
Reports that the administration has established a procedure that would remove the Centers for Disease Control and Prevention as a recipient of data on patients hospitalized with COVID-19 are troubling and, if implemented, will undermine our nation’s public health experts.
As societies of infectious diseases physicians, scientists, public health practitioners and frontline health providers, we recognize the need to balance concerns surrounding the ongoing COVID-19 pandemic with community concerns
“We are disappointed in the administration's decision to abandon the WHO. America needs to join with the global scientific community in fighting the virus, not go it alone..."
“The administration’s decision to withdraw from the WHO will not only leave the United States more vulnerable to COVID-19 and future pandemics, but it will be a major setback to our efforts to control the HIV pandemic here at home and abroad."
A newer therapy that acts like a Trojan horse to attack bacteria should be reserved for patients with certain treatment-refractory lung infections, according to updated nontuberculous mycobacterial (NTM) pulmonary disease guidelines released by the IDSA, the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the European Society of Clinical Microbiology and Infectious Disease (ESCMID).
As the COVID-19 pandemic continues to challenge health care professionals across the nation, the IDSA and the CDC have partnered to build connections across health care disciplines and to provide access to the latest information on fighting the disease that has ended the lives of more than 100,000 Americans and affected even more.
Reports that the White House may be considering significantly reducing the role of the Centers for Disease Control and Prevention are deeply concerning. America remains at the center of a global pandemic and needs well-established, credible scientists—not political appointees—informing public health decisions.
The rules in the Patient Protection and Affordable Care Act barring discrimination by health insurers and providers against transgender people offered essential protections for a population facing significant barriers to health care.
As strict stay-at-home orders are suspended in states across the country and mass calls for racial justice continue to bring large numbers of people together, individual protective measures as well as responsive public policies and resources will be paramount to controlling the spread of COVID-19.